Shares outstanding decreased 96.7%
Shares outstanding changed -96.7% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -96.7% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Working capital / assets changed +5344 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed +31.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed +28.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -23.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +21.6% from the comparable as-filed period.
Operating cash flow changed +5.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -4.0% from the comparable as-filed period.
Total assets changed +10.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed -2.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +1.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.